← Back to patent-cliff list
CAS 2044680-93-3
(1aR,2S,3S,5S,6S,10S,10aS,11aS)-10-[(Benzyloxy)methoxy]-5-hydroxy-2,10a,12,12-tetramethyl-3,4,5,6,8,9,10,10a,11,11a-decahydro-2H-2,3-epoxy-1a,5-methanobenzo[4,5]cyclodeca[1,2-b]oxiren-6-yl benzoate
Codes: (XX)101438-60-b
Application context (from source-drug indications)
Breast cancerPaclitaxel/Encequidar mesylateAdenocarcinomaPaclitaxel/Encequidar mesylateAngiosarcomaPaclitaxel/Encequidar mesylateSolid tumourPaclitaxel/Encequidar mesylatePancreatic cancerPaclitaxelNon-small cell lung cancerPaclitaxelHodgkin's diseasePaclitaxelSeminomaPaclitaxelOvarian cancerPaclitaxelBreast cancerPaclitaxel
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Paclitaxel/Encequidar mesylate | Tier C — Watch / trade | - |
| Paclitaxel | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Lithiumbenzene→(4S,5S)-5-[(5S,6S)-5-[(Benzyloxy)methoxy]-6-methyl-6-(prop-2-en-1-yl)cyclohex-1-en-1-yl]-4-(3-methylbut-2-en-1-yl)-4-(2-methylpent-3-yn-2-yl)-1,3-dioxolan-2-one→(3aS,7Z,9aS,10S,13bS)-10-[(Benzyloxy)methoxy]-6,9a,14,14-tetramethyl-9,9a,10,11,12,13b-hexahydro-2H,4H-3a,7-methanobenzo[3,4]cyclodeca[1,2-d][1,3]dioxol-2-one→(1aR,1bS,2aS,3aS,6aS,10S,10aS,11aS)-10-[(Benzyloxy)methoxy]-1b,10a,12,12-tetramethyl-2a,3,8,9,10,10a,11,11a-octahydro-1bH,5H,6aH-1a,3a-methanobenzo[3,4]bisoxireno[6,7:8,9]cyclodeca[1,2-d][1,3]dioxol-5-one→(1aR,2S,3S,5S,6S,10S,10aS,11aS)-10-[(Benzyloxy)methoxy]-5-hydroxy-2,10a,12,12-tetramethyl-3,4,5,6,8,9,10,10a,11,11a-decahydro-2H-2,3-epoxy-1a,5-methanobenzo[4,5]cyclodeca[1,2-b]oxiren-6-yl benzoate→(1S,5S,6S,8S,11S,12aS)-1-[(Benzyloxy)methoxy]-6,8,11-trihydroxy-9,12a,13,13-tetramethyl-1,2,3,5,6,7,8,11,12,12a-decahydro-6,10-methanobenzo[10]annulen-5-yl benzoate→(1S,5S,6S,8S,11S,12aS)-1-[(Benzyloxy)methoxy]-6,8-dihydroxy-9,12a,13,13-tetramethyl-11-[(triethylsilyl)oxy]-1,2,3,5,6,7,8,11,12,12a-decahydro-6,10-methanobenzo[10]annulen-5-yl benzoate
Lithiumbenzene→(4S,5S)-5-[(5S,6S)-5-[(Benzyloxy)methoxy]-6-methyl-6-(prop-2-en-1-yl)cyclohex-1-en-1-yl]-4-(3-methylbut-2-en-1-yl)-4-(2-methylpent-3-yn-2-yl)-1,3-dioxolan-2-one→(3aS,7Z,9aS,10S,13bS)-10-[(Benzyloxy)methoxy]-6,9a,14,14-tetramethyl-9,9a,10,11,12,13b-hexahydro-2H,4H-3a,7-methanobenzo[3,4]cyclodeca[1,2-d][1,3]dioxol-2-one→(1aR,1bS,2aS,3aS,6aS,10S,10aS,11aS)-10-[(Benzyloxy)methoxy]-1b,10a,12,12-tetramethyl-2a,3,8,9,10,10a,11,11a-octahydro-1bH,5H,6aH-1a,3a-methanobenzo[3,4]bisoxireno[6,7:8,9]cyclodeca[1,2-d][1,3]dioxol-5-one→(1aR,2S,3S,5S,6S,10S,10aS,11aS)-10-[(Benzyloxy)methoxy]-5-hydroxy-2,10a,12,12-tetramethyl-3,4,5,6,8,9,10,10a,11,11a-decahydro-2H-2,3-epoxy-1a,5-methanobenzo[4,5]cyclodeca[1,2-b]oxiren-6-yl benzoate→(1S,5S,6S,8S,11S,12aS)-1-[(Benzyloxy)methoxy]-6,8,11-trihydroxy-9,12a,13,13-tetramethyl-1,2,3,5,6,7,8,11,12,12a-decahydro-6,10-methanobenzo[10]annulen-5-yl benzoate→(1S,5S,6S,8S,11S,12aS)-1-[(Benzyloxy)methoxy]-6,8-dihydroxy-9,12a,13,13-tetramethyl-11-[(triethylsilyl)oxy]-1,2,3,5,6,7,8,11,12,12a-decahydro-6,10-methanobenzo[10]annulen-5-yl benzoate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.